Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A still from the animation about Lysosomal Storage Diseases shows families at a conference to find out more about the disease that is affecting their family

The first of three web-based short animations have been launched about Lysosomal Storage Diseases, designed for lay audiences and aimed at newly diagnosed families. The aim is to connect patients and their families with support organisations.

The video was made in partnership between the Platt lab, Department of Pharmacology, University of Oxford and lysosomal disease patient associations. It was funded by an Enriching Engagement Grant from the Wellcome Trust. The project team will be monitoring viewers’ engagement with the videos and collecting anonymised metrics and survey data.

The animation is available in fourteen different languages – you can view the English version here (e-mail rizwana.rashid@pharm.ox.ac.uk for links to the presentation in other languages).

Similar stories

EMA approval of IntraBio’s Aqneursa marks a major milestone for the Department of Pharmacology, with further Phase 3 success in Ataxia Telangiectasia

On 21 January, the European Medicines Agency (EMA) approved Aqneursa, a new treatment for Niemann-Pick Disease Type C (NPC) in adults and children, marking a major milestone for research originating in the Department of Pharmacology. Aqneursa already received US FDA approval (September 2024), enabling patient access on both sides of the Atlantic.